Jason D. Sadler - 24 Feb 2023 Form 4 Insider Report for Cigna Group (CI)

Role
Pres., International Health
Signature
Kevin Ciaglo, attorney-in-fact
Issuer symbol
CI
Transactions as of
24 Feb 2023
Transactions value $
$0
Form type
4
Filing time
28 Feb 2023, 17:02:26 UTC
Previous filing
24 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +5.07K +12.09% $0.00 47K 24 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2020-2022 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.